Ispire (ISPR) Q3 2026 earnings review
Shrinking Revenue, but Cash Burn Halts Amid Strategic Pivot
Ispire's Q3 2026 results reflect a company undergoing a painful but necessary transition. Total revenue decelerated 29% YoY to $18.7 million as the company continues to aggressively exit its legacy cannabis hardware business. While management touted 'business stabilization,' the financial reality is mixed: the net loss expanded sequentially from $6.6 million in Q2 to $9.5 million in Q3, largely driven by a brutal $2.2 million hit from legacy cannabis product returns and $5.6 million in bad debt. On the positive side, disciplined cost controls slashed core operating expenses by 36%, and cash actually grew sequentially by $468,000 to $18 million. With Malaysian manufacturing now live to bypass China tariffs, the focus shifts to 2H 2026 to achieve promised cash flow positivity.
🐂 Bull Case
Operating expenses (excluding bad debt) plummeted 36% YoY to $5.9M. Combined with working capital improvements, this allowed Ispire to generate $468,000 in cash sequentially, avoiding dilutive capital raises in a challenging environment.
The new Malaysian manufacturing facility is now fully live, granting Ispire an estimated 25% tariff advantage over Chinese imports—a massive catalyst as U.S. geopolitical tensions remain high.
🐻 Bear Case
The exit from low-quality cannabis customers remains messy. A $2.2M wave of product returns collapsed gross margins to 10.7%, while $5.6M in bad debt wiped out operating leverage.
Sales have fallen for three consecutive quarters. Until the Vapor ODM and age-gating technologies launch in late 2026/2027, the top-line growth narrative remains deeply impaired.
⚖️ Verdict: ⚪
Neutral. The halt in cash burn is an impressive feat, and avoiding the China tariff trap is smart. However, the top-line contraction and persistent cannabis write-offs prove the transition is far from over.
Key Themes
Cannabis Pivot Crushes Gross Margins
Gross margin reversed sharply, plunging to 10.7% from 18.2% a year ago. The culprit: $2.2 million in one-time product returns from legacy cannabis customers. Management frames this as 'ceasing doing business' with bad actors, but this write-off contradicts the prior narrative that the 'quality over quantity' customer shift had already stabilized the U.S. business.
Bad Debt Remains Stubbornly High
Credit loss expenses (bad debt) hit $5.6 million this quarter. While slightly down from $6.1 million a year ago, it represents a massive 30% of total revenue. Squeezing cash out of the systemic constraints in the U.S. cannabis hardware sector continues to drag down the income statement.
OpEx Restructuring Taking Hold
Accelerating cost controls are saving the balance sheet. Total operating expenses excluding bad debt dropped 36% YoY (from $9.3M to $5.9M). This directly reflects the successful relocation of back-office functions to the Malaysian campus to streamline operations.
Malaysian Facility Secures Macro Tariff Advantage
Management confirmed that Malaysian manufacturing is officially live. This structurally de-risks the company from U.S.-China trade tensions, affording Ispire a 25% tariff advantage over Chinese imports. This positions the company aggressively against competitors struggling with 'landed costs' in the $73B global vape market.
Transformative Technology Roadmap Deployed
Management laid out a clear timeline to commercialize its tech stack. The Vapor ODM business launches in July 2026 for mid-sized brands. Moving into 2027, the IKE Tech age-gating solution (targeting the locked $50-70B U.S. flavored market) and G-Mesh glass technology (drawing Big Tobacco interest) are slated to go live, shifting Ispire from hardware manufacturer to IP licensor.
Other KPIs
Despite a $9.5M net loss, cash increased sequentially by $468,000, reversing the severe cash drain seen in prior fiscal years. However, working capital is precariously tight at just $0.9M. Total current liabilities dropped from $72.5M to $54.8M over the past 9 months, largely due to paying down related-party payables.
Decelerating. Down from $15.4 million in Q3 FY25. The 25% drop was primarily driven by massive cuts in general and administrative expenses (down to $4.8M from $7.6M) and sales and marketing expenses (down to $1.1M from $1.7M).
Guidance
Management expects to turn cash flow positive in the second half of calendar year 2026. This represents a delay from prior expectations (which previously targeted March 2025), but the current quarter's sequential cash addition provides tangible evidence they are nearing this goal.
Management officially scheduled the launch of Vapor ODM for mid-sized brands for July 2026, with large brand partnerships targeted for 2027.
Key Questions
End of Legacy Write-Downs
With another $2.2M in product returns and $5.6M in bad debt this quarter, when will the financial bleed from the legacy cannabis hardware business be completely ring-fenced from the income statement?
Malaysian Capacity Utilization
Now that Malaysian manufacturing is live and offering a 25% tariff advantage, what percentage of Q3's $18.7M revenue was produced there, and how quickly can you transition the remainder?
Vapor ODM Revenue Visibility
With the Vapor ODM launch slated for July 2026, do you have binding purchase orders from these 'mid-sized brands', and what is the expected revenue contribution for the back half of the year?